ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,534Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 4623

$1.23M Total Retail Price of All Prescriptions

Rank: 83 out of 4623

612 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 612 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

42% of this provider’s 612 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

5% of this provider’s 19,380 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 966 901 1 1
METOPROLOL TARTRATE 908 813 2 9
HYDROCODONE-ACETAMINOPHEN 880 744 S3 3 3
OMEPRAZOLE 788 718 4 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 782 735 5 19
SIMVASTATIN 761 694 6 2
DOXAZOSIN MESYLATE 730 702 7 98
GLYBURIDE-METFORMIN HCL 606 572 R 8 56
NEXIUM 595 527 9 17
CRESTOR 447 427 10 20
FUROSEMIDE 442 410 11 8
PRAVASTATIN SODIUM 431 400 12 11
TAMSULOSIN HCL 421 402 13 29
ALLOPURINOL 398 370 14 37
LOSARTAN-HYDROCHLOROTHIAZIDE 391 347 15 46
PANTOPRAZOLE SODIUM 367 341 16 35
ATORVASTATIN CALCIUM 321 285 17 12
AVODART 316 299 18 172
ISOSORBIDE MONONITRATE ER 310 281 19 60
CIPROFLOXACIN HCL 308 282 20 43
TRICOR 292 253 21 88
DONEPEZIL HCL 276 270 22 30
CARVEDILOL 259 232 23 25
DIOVAN HCT 243 228 24 67
GLIMEPIRIDE 239 212 25 38
DIOVAN 207 198 26 39
SERTRALINE HCL 207 188 26 26
NAMENDA 187 187 28 36
GABAPENTIN 176 166 29 16
HYDRALAZINE HCL 174 136 30 99
LOSARTAN POTASSIUM 169 152 31 21
POTASSIUM CHLORIDE 167 161 32 14
ALENDRONATE SODIUM 163 129 33 22
METFORMIN HCL 162 140 34 6
PREDNISONE 161 136 35 50
CLOPIDOGREL 159 132 36 31
AMLODIPINE BESYLATE 155 122 37 5
CLONIDINE HCL 153 131 38 40
ENALAPRIL MALEATE 148 137 39 41
SUCRALFATE 145 131 40 183
KLOR-CON M20 140 136 41 102
NAPROXEN 133 125 42 63
CILOSTAZOL 124 98 43 176
METOCLOPRAMIDE HCL 123 115 44 126
MEGESTROL ACETATE 122 119 R 45 145
LISINOPRIL 121 113 46 4
BYSTOLIC 117 117 47 115
LANTUS 116 88 48 44
LEVEMIR 109 92 49 154
AGGRENOX 109 109 49 198
SPIRIVA 103 100 51 79
MELOXICAM 102 85 52 27
WARFARIN SODIUM 100 79 53 24
LEVEMIR FLEXPEN 89 86 54 167
PLAVIX 87 75 55 45
AMITRIPTYLINE HCL 84 54 R 56 69
RANITIDINE HCL 82 75 57 47
INSULIN SYRINGE 81 68 58 85
PAROXETINE HCL 77 71 59 78
JANUMET 74 74 60 136
CLOTRIMAZOLE-BETAMETHASONE 71 60 61 147
ALBUTEROL SULFATE 69 69 62 142
CARBIDOPA-LEVODOPA 69 69 62 116
ENABLEX 68 61 64 274
ZOLPIDEM TARTRATE 65 61 65 18
PROMETHAZINE HCL 63 57 R 66 93
FLUCONAZOLE 61 58 67 189
RIVASTIGMINE 61 61 67 375
DICYCLOMINE HCL 61 61 67 238
CYCLOBENZAPRINE HCL 58 53 R 70 53
LIPITOR 55 54 71 100
DIVALPROEX SODIUM 55 48 71 90
ADVAIR DISKUS 54 51 73 62
DICLOFENAC SODIUM 53 51 74 121
NYSTATIN 53 52 74 175
VALSARTAN-HYDROCHLOROTHIAZIDE 53 48 74 351
SPIRONOLACTONE 52 50 77 77
FINASTERIDE 51 51 78 109
MIRTAZAPINE 50 49 79 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.